Developer docs
API playgroundTry for free, no card

Search company profiles

Wellinks

Full company profile

uuid0000xeq

Namestring
Wellinks
Legal namestring
Wellinks
Websiteurl
wellinks.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Wellinks is a virtual-first chronic cardiopulmonary care management company that delivers integrated remote monitoring, mobile health tools, and respiratory therapy coaching to patients with COPD, asthma, ILD, and other chronic respiratory diseases, alongside the Medicare Advantage plans, health insurers, health systems, risk-bearing entities, and primary care practices that fund their care. Founded in 2014 and headquartered at 85 Willow Street in New Haven, Connecticut, the company operates with 11-50 employees and is privately held.

The company's core technology stack combines the Spire RPM System acquired from Spire Health in September 2024, the Wellinks mobile application available on iOS and Android that integrates with Bluetooth-connected pulse oximeters and spirometers, Zoom-delivered one-on-one virtual coaching sessions with respiratory therapists, and a content library spanning breathing techniques, therapeutic singing, nutrition, medication management, and lifestyle education. Continuous structured physiological data (SpO2, heart rate, respiratory and activity metrics) feeds a Predictive Patient Care model designed to flag deterioration and trigger early intervention before exacerbations escalate. Wellinks holds SOC 2 Type II certification and operates HIPAA-compliant telehealth infrastructure.

Revenue is generated through B2B contracts with payers and providers on a recurring subscription basis, supplemented by usage-based reimbursement via Remote Patient Monitoring CPT codes. The go-to-market is sales-led, targeting Medicare Advantage plans and health systems as primary buyers, while patient-facing services are delivered through the mobile application and virtual coaching channels. The company has raised approximately $42.6M across four disclosed funding rounds between 2016 and 2021, with the most recent Series C of $25M led by 5Y Capital.

Short descriptiontext

Wellinks is a virtual-first chronic cardiopulmonary care company delivering remote patient monitoring, mobile health tools, and respiratory therapy coaching to patients with COPD and related conditions, funded through B2B contracts with Medicare Advantage plans, health systems, and insurers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew Haven, United States
HQ citystring
New Haven
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
chronic care management, remote patient monitoring, pulmonary rehabilitation, virtual coaching, cardiopulmonary health
Industry4 codes
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAH
Virtual Nursing, Telemonitoring & Command Center Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SIC code1 code
  • Services-Health Services8000
Product category
Chronic Care Management Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Payer and Provider Partnerships
TypeSubscription Recurring
Description

Wellinks generates revenue through partnerships with health systems, Medicare Advantage plans, health insurers, and healthcare providers who pay for the company's care management and remote patient monitoring services to manage their COPD and chronic pulmonary patient populations.

wellinks.com
2RPM Reimbursement
TypeUsage Based
Description

The company leverages Remote Patient Monitoring (RPM) CPT codes for reimbursement, enabling healthcare providers to bill for the monitoring services Wellinks provides, including collection and interpretation of physiological data.

wellinks.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Wellinks is a virtual-first chronic cardiopulmonary care management company that combines a mobile application, Bluetooth-connected medical devices (pulse oximeter, spirometer), and virtual coaching from respiratory therapists to deliver COPD education, remote monitoring, and pulmonary rehabilitation. Its Predictive Patient Care model, powered by the acquired Spire RPM System, uses continuous physiological data and predictive analytics to enable proactive interventions for patients and their healthcare payers/providers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced emergency inhaler use reported by patients
+2 more records
Product overview1 text field

Wellinks is a virtual-first chronic pulmonary care management company offering an integrated platform combining remote patient monitoring technology, mobile applications, and virtual coaching services. The core portfolio includes the Spire RPM System (acquired technology for continuous physiological monitoring), the Wellinks Predictive Patient Care model, and the Wellinks mobile application for iOS and Android. The platform integrates Bluetooth-connected medical devices including pulse oximeters, provides educational resources for COPD management, delivers virtual coaching sessions via Zoom, and offers round-the-clock nurse support through the Wellinks Support Line.

Product and service3 records
1Spire RPM System
CategoryRemote Patient Monitoring
Description

Remote patient monitoring technology that captures continuous respiratory and activity data via connected devices, enabling early detection of health changes and predictive interventions for cardiopulmonary patients. Sold to healthcare payers, providers, and risk-bearing entities managing COPD populations.

2Predictive Patient Care
CategoryChronic Care Management
Description

A care delivery model combining continuous RPM data with predictive analytics to enable proactive, early intervention in cardiopulmonary care. Integrates Spire's monitoring technology with Wellinks' virtual coaching and pulmonary rehabilitation programs. Sold to enterprise healthcare buyers.

3Wellinks Mobile Application
CategoryPatient Engagement Software
Description

Patient-facing mobile app on iOS and Android that serves as the primary interface for tracking health metrics (SpO2, BPM), recording Bluetooth-connected pulse oximetry readings, accessing educational content and exercise programs, connecting with care coaches, and managing COPD action plans.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Spire Health
Strategic tierCoreTypeTechnology or Integration
Description

Wellinks acquired Spire Health and its cutting-edge patient monitoring technology. This acquisition enables Wellinks to offer predictive patient care through Spire's remote monitoring system, setting a new standard in cardiopulmonary care delivery. The integration combines Spire's RPM technology with Wellinks' coaching and education programs.

wellinks.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Propeller Health, acquired by ResMed, is the leading direct competitor in respiratory-focused remote patient monitoring. It attaches sensors to inhalers and partners with payers and providers, mirroring Wellinks' COPD RPM plus payer distribution model.

2Biofourmis
TypeDirect peer
Description

Biofourmis is an RPM platform that combines continuous biosensor data with predictive AI for chronic disease management, closely paralleling Wellinks' Predictive Patient Care model. Its care-at-home programs target cardiology and other chronic populations with similar payer and provider contracts.

TypeDirect peer
Description

Vivify Health provides a connected care RPM platform serving chronic and post-acute patients through health system and payer contracts. Its mobile app plus device integration and care management workflows are directly comparable to Wellinks' technology stack and GTM motion.

TypeDirect peer
Description

Eko Health builds cardiopulmonary sensing devices and AI-driven analytics used by clinicians for cardiac and respiratory monitoring. Its combination of proprietary hardware and AI analytics for cardiopulmonary disease overlaps with Wellinks' Spire-based RPM and predictive care offering.

5Care Innovations
TypeDirect peer
Description

Care Innovations, an Intel spinoff now owned by PCA Doctors, delivers RPM and virtual care platforms to health systems and payers for chronic condition management. It competes for the same enterprise contracts Wellinks targets and uses similar Bluetooth device-plus-coaching workflows.

6Smart Meter
TypeDirect peer
Description

Smart Meter supplies connected RPM devices and data platforms for chronic disease monitoring, including cellular-enabled health devices used by payers and providers. Its hardware-plus-platform approach and chronic care focus make it a comparable peer to Wellinks' Spire-based RPM offering.

TypeDirect peer
Description

Lark Health offers AI-driven chronic disease coaching and remote monitoring through a mobile app with payer and provider contracts. Its digital coaching-first model for chronic conditions closely mirrors Wellinks' virtual respiratory therapist coaching approach.

TypeBroad incumbent
Description

ResMed is a global leader in sleep and respiratory devices and acquired Propeller Health to extend into RPM. Its installed base of CPAP and respiratory patients, plus payer relationships, makes it a broad incumbent competitor that can bundle RPM into existing respiratory care contracts.

TypeBroad incumbent
Description

Omada Health is a digital chronic disease management company selling to employers, health plans, and providers across diabetes, hypertension, and musculoskeletal conditions. Its B2B virtual care model with digital coaching parallels Wellinks' payer-facing chronic care motion, though it is broader in therapeutic scope.

TypeBroad incumbent
Description

Hinge Health is a large digital musculoskeletal and chronic pain platform that partners with health plans and employers. While its primary focus is MSK rather than pulmonary, its B2B digital care model with outcomes-based contracting overlaps with Wellinks' enterprise GTM strategy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wellinks

Chronic Care Management Softwarewellinks.com

Wellinks is a virtual-first chronic cardiopulmonary care company delivering remote patient monitoring, mobile health tools, and respiratory therapy coaching to patients with COPD and related conditions, funded through B2B contracts with Medicare Advantage plans, health systems, and insurers.

What Wellinks does

Wellinks is a virtual-first chronic cardiopulmonary care management company that delivers integrated remote monitoring, mobile health tools, and respiratory therapy coaching to patients with COPD, asthma, ILD, and other chronic respiratory diseases, alongside the Medicare Advantage plans, health insurers, health systems, risk-bearing entities, and primary care practices that fund their care. Founded in 2014 and headquartered at 85 Willow Street in New Haven, Connecticut, the company operates with 11-50 employees and is privately held.

The company's core technology stack combines the Spire RPM System acquired from Spire Health in September 2024, the Wellinks mobile application available on iOS and Android that integrates with Bluetooth-connected pulse oximeters and spirometers, Zoom-delivered one-on-one virtual coaching sessions with respiratory therapists, and a content library spanning breathing techniques, therapeutic singing, nutrition, medication management, and lifestyle education. Continuous structured physiological data (SpO2, heart rate, respiratory and activity metrics) feeds a Predictive Patient Care model designed to flag deterioration and trigger early intervention before exacerbations escalate. Wellinks holds SOC 2 Type II certification and operates HIPAA-compliant telehealth infrastructure.

Revenue is generated through B2B contracts with payers and providers on a recurring subscription basis, supplemented by usage-based reimbursement via Remote Patient Monitoring CPT codes. The go-to-market is sales-led, targeting Medicare Advantage plans and health systems as primary buyers, while patient-facing services are delivered through the mobile application and virtual coaching channels. The company has raised approximately $42.6M across four disclosed funding rounds between 2016 and 2021, with the most recent Series C of $25M led by 5Y Capital.

Wellinks firmographics

Firmographics
Name
Wellinks
Legal name
Wellinks
Website
https://wellinks.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Wellinks is a virtual-first chronic cardiopulmonary care company delivering remote patient monitoring, mobile health tools, and respiratory therapy coaching to patients with COPD and related conditions, funded through B2B contracts with Medicare Advantage plans, health systems, and insurers.
Ownership category
akta.pro rank

Wellinks industry classification

Industry
Product category
Chronic Care Management Software
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAH
Virtual Nursing, Telemonitoring & Command Center Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Chronic care management
  • Remote patient monitoring
  • Pulmonary rehabilitation
  • Virtual coaching
  • Cardiopulmonary health

Where Wellinks is headquartered

Location

Headquarters

HQ city
New Haven
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Wellinks business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Healthcare Payer and Provider Partnerships: Wellinks generates revenue through partnerships with health systems, Medicare Advantage plans, health insurers, and healthcare providers who pay for the company's care management and remote patient monitoring services to manage their COPD and chronic pulmonary patient populations.
  2. RPM Reimbursement: The company leverages Remote Patient Monitoring (RPM) CPT codes for reimbursement, enabling healthcare providers to bill for the monitoring services Wellinks provides, including collection and interpretation of physiological data.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Wellinks product offering

Product offering

Core offering

Wellinks is a virtual-first chronic cardiopulmonary care management company that combines a mobile application, Bluetooth-connected medical devices (pulse oximeter, spirometer), and virtual coaching from respiratory therapists to deliver COPD education, remote monitoring, and pulmonary rehabilitation. Its Predictive Patient Care model, powered by the acquired Spire RPM System, uses continuous physiological data and predictive analytics to enable proactive interventions for patients and their healthcare payers/providers.

Product overview

Wellinks is a virtual-first chronic pulmonary care management company offering an integrated platform combining remote patient monitoring technology, mobile applications, and virtual coaching services. The core portfolio includes the Spire RPM System (acquired technology for continuous physiological monitoring), the Wellinks Predictive Patient Care model, and the Wellinks mobile application for iOS and Android. The platform integrates Bluetooth-connected medical devices including pulse oximeters, provides educational resources for COPD management, delivers virtual coaching sessions via Zoom, and offers round-the-clock nurse support through the Wellinks Support Line.

Differentiator

Problem solved

Functional benefit

Products and services

  • Spire RPM System Remote patient monitoring technology that captures continuous respiratory and activity data via connected devices, enabling early detection of health changes and predictive interventions for cardiopulmonary patients. Sold to healthcare payers, providers, and risk-bearing entities managing COPD populations.
  • Predictive Patient Care A care delivery model combining continuous RPM data with predictive analytics to enable proactive, early intervention in cardiopulmonary care. Integrates Spire's monitoring technology with Wellinks' virtual coaching and pulmonary rehabilitation programs. Sold to enterprise healthcare buyers.
  • Wellinks Mobile Application Patient-facing mobile app on iOS and Android that serves as the primary interface for tracking health metrics (SpO2, BPM), recording Bluetooth-connected pulse oximetry readings, accessing educational content and exercise programs, connecting with care coaches, and managing COPD action plans.

Quantifiable outcome

  • Reduced emergency inhaler use reported by patients
  • +2 more outcomes

Companies that use Wellinks

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Wellinks technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature5 records

Wellinks partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Spire HealthcoreTechnology or IntegrationWellinks acquired Spire Health and its cutting-edge patient monitoring technology. This acquisition enables Wellinks to offer predictive patient care through Spire's remote monitoring system, setting a new standard in cardiopulmonary care delivery. The integration combines Spire's RPM technology with Wellinks' coaching and education programs.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Wellinks competitors and assessment

Company assessment

Direct peers

  • Propeller Health: Propeller Health, acquired by ResMed, is the leading direct competitor in respiratory-focused remote patient monitoring. It attaches sensors to inhalers and partners with payers and providers, mirroring Wellinks' COPD RPM plus payer distribution model.
  • Biofourmis: Biofourmis is an RPM platform that combines continuous biosensor data with predictive AI for chronic disease management, closely paralleling Wellinks' Predictive Patient Care model. Its care-at-home programs target cardiology and other chronic populations with similar payer and provider contracts.
  • Vivify Health: Vivify Health provides a connected care RPM platform serving chronic and post-acute patients through health system and payer contracts. Its mobile app plus device integration and care management workflows are directly comparable to Wellinks' technology stack and GTM motion.
  • Eko Health: Eko Health builds cardiopulmonary sensing devices and AI-driven analytics used by clinicians for cardiac and respiratory monitoring. Its combination of proprietary hardware and AI analytics for cardiopulmonary disease overlaps with Wellinks' Spire-based RPM and predictive care offering.
  • Care Innovations: Care Innovations, an Intel spinoff now owned by PCA Doctors, delivers RPM and virtual care platforms to health systems and payers for chronic condition management. It competes for the same enterprise contracts Wellinks targets and uses similar Bluetooth device-plus-coaching workflows.
  • Smart Meter: Smart Meter supplies connected RPM devices and data platforms for chronic disease monitoring, including cellular-enabled health devices used by payers and providers. Its hardware-plus-platform approach and chronic care focus make it a comparable peer to Wellinks' Spire-based RPM offering.
  • Lark Health: Lark Health offers AI-driven chronic disease coaching and remote monitoring through a mobile app with payer and provider contracts. Its digital coaching-first model for chronic conditions closely mirrors Wellinks' virtual respiratory therapist coaching approach.

Broad incumbents

  • ResMed: ResMed is a global leader in sleep and respiratory devices and acquired Propeller Health to extend into RPM. Its installed base of CPAP and respiratory patients, plus payer relationships, makes it a broad incumbent competitor that can bundle RPM into existing respiratory care contracts.
  • Omada Health: Omada Health is a digital chronic disease management company selling to employers, health plans, and providers across diabetes, hypertension, and musculoskeletal conditions. Its B2B virtual care model with digital coaching parallels Wellinks' payer-facing chronic care motion, though it is broader in therapeutic scope.
  • Hinge Health: Hinge Health is a large digital musculoskeletal and chronic pain platform that partners with health plans and employers. While its primary focus is MSK rather than pulmonary, its B2B digital care model with outcomes-based contracting overlaps with Wellinks' enterprise GTM strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Wellinks social profiles

Digital presence

Wellinks compliance and trust

Trust signal

Compliance1 record

Wellinks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wellinks leadership team

Management profile

Number of profiles

Wellinks subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Wellinks funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wellinks M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellinks

What does Wellinks do?

Wellinks is a virtual-first chronic cardiopulmonary care management company that combines a mobile application, Bluetooth-connected medical devices (pulse oximeter, spirometer), and virtual coaching from respiratory therapists to deliver COPD education, remote monitoring, and pulmonary rehabilitation. Its Predictive Patient Care model, powered by the acquired Spire RPM System, uses continuous physiological data and predictive analytics to enable proactive interventions for patients and their healthcare payers/providers.

Is Wellinks a public or private company?

Wellinks is a private company. It is classified as venture growth investor backed and is currently operating.

When was Wellinks founded?

Wellinks was founded in 2014. It employs 11 to 50 people.

Where is Wellinks based?

Wellinks is headquartered in New Haven, United States, in the North America region.

How does Wellinks make money?

Two revenue lines are on record. Healthcare Payer and Provider Partnerships are the primary driver. The others are RPM Reimbursement.

Who are Wellinks's main competitors?

Direct peers on record are Propeller Health, Biofourmis, Vivify Health, Eko Health, Care Innovations, Smart Meter and Lark Health. Broad incumbents are ResMed, Omada Health and Hinge Health.

Does Wellinks have an API?

No public API is recorded for Wellinks.

What industry is Wellinks in?

Wellinks's product category is Chronic Care Management Software. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea). Its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SecSEC FORM DConvexity Scientific Inc. filed a Form D notice with the SEC on November 8, 2021, disclosing an exempt offering of pooled investment fund interests under Rule 506(b). The company raised $24,999,948 from seven investors, with no sales commissions or finder's fees, and no proceeds allocated to named executives, directors or promoters.GlobeNewswireConvexity Scientific Announces New PartnershipConvexity Scientific announced a partnership with Capsule to make its Flyp Nebulizer available to health care providers and patients in the New York City area. Capsule joins over 400 providers nationwide as an authorized distributor. The nebulizer delivers up to 90% of prescribed medication in seven minutes.ForbesMeet The Award-Winning Medical Device With A Design Inspired By E-CigarettesConvexity Scientific introduced the Flyp, a portable nebulizer inspired by e-cigarette technology, to address the limitations of traditional bulky devices. The company has raised over $4 million in funding and aims to capture 20% of the U.S. market within two years of its June 2018 launch.GlobeNewswireConvexity Scientific Closes Equity InvestmentConvexity Scientific closed an equity investment round led by Connecticut Innovations, Benslie Limited, and Stonehenge Growth Capital. The company will use the funds to accelerate go-to-market activities, including hiring sales staff and marketing efforts. Its first product, a handheld nebulizer for respiratory diseases, was recently cleared by the FDA.